AbbVie
ABBV
ABBV
1,650 hedge funds and large institutions have $80.1B invested in AbbVie in 2015 Q2 according to their latest regulatory filings, with 123 funds opening new positions, 681 increasing their positions, 634 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,650
Holders Change
+52
Holders Change %
+3.25%
% of All Funds
44.5%
Holding in Top 10
142
Holding in Top 10 Change
+61
Holding in Top 10 Change %
+75.31%
% of All Funds
3.83%
New
123
Increased
681
Reduced
634
Closed
57
Calls
$1.49B
Puts
$1.21B
Net Calls
+$274M
Net Calls Change
-$1.84M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$2.78B |
| 2 |
GCM
Glenview Capital Management
New York
|
$1.2B |
| 3 |
BBA
Baker Bros. Advisors
New York
|
$966M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$2.12B |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$6.79B |
